ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE
发明人:
申请号:
EP09825478.2
公开号:
EP2349454B1
申请日:
2009.11.06
申请国别(地区):
EP
年份:
2016
代理人:
摘要:
The present invention relates generally to the use of erythropoietin (EPO) to facilitate resuscitation from cardiac arrest. For a mammalian subject suffering from cardiac arrest, concurrent administration of EPO with resuscitation after the onset of ventricular fibrillation facilitates the resuscitation. Administration of EPO serves to attenuate myocardial abnormalities caused by cardiac arrest and the resuscitation efforts and favor improved resuscitation outcomes.